skip to main content

ATRO Medical

Artificial meniscus

ATRO Medical is developing an artificial meniscus Trammpolin®. This medical device is indicated for patients with a dysfunctional meniscus and persistent pain, where conservative treatment options have failed. Extensive in vitro testing is conducted first to ensure that the Trammpolin® device effectively imitates the behaviour of the natural meniscus.

Albert van der Veen, Scenior Scientist

Jan Hunik, CEO: "Device integrity is a key aspect for acceptance of a meniscus prosthesis by the Orthopaedic community. Mibiton's investment enables ATRO Medical to become the leading medical device company in the development of meniscus prostheses and provide a sustainable solution for patients with chronic knee pain."

www.atromedical.com